The Gruzman Lab Drug Development

Development of anti-inflammatory peptidomimetics based on the structure of human alpha1-antitrypsin.

Lior Y.; Shtriker E.; Kahremany S.; Lewis E.; Gruzman A., 2022

European Journal of Medicinal Chemistry, 228: 113969.
https://www.sciencedirect.com/science/article/pii/S0223523421008187